Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus

Clin Infect Dis. 2002 Sep 1;35(5):e57-9. doi: 10.1086/341982. Epub 2002 Aug 6.

Abstract

We report the first case of acute cholecystitis due to indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus who had been receiving indinavir for 56 months. Infrared spectroscopy demonstrated that the gallstone was composed of indinavir monohydrate (50%), calcium bilirubinate (28%), calcium palmitate (10%), cholesterol (7%), and proteins (5%). The role of high-level chronic unconjugated hyperbilirubinemia coupled with high blood concentrations of indinavir is discussed.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Bilirubin / analysis
  • Cholelithiasis / chemically induced*
  • Cholelithiasis / chemistry
  • Cholesterol / analysis
  • HIV Infections / complications*
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / metabolism
  • Humans
  • Indinavir / adverse effects*
  • Indinavir / metabolism
  • Male
  • Palmitic Acid / analysis

Substances

  • HIV Protease Inhibitors
  • Palmitic Acid
  • Indinavir
  • Cholesterol
  • Bilirubin